Transparency campaigners make gains in clinical trials battleBMJ 2013; 347 doi: https://doi.org/10.1136/bmj.f7585 (Published 17 December 2013) Cite this as: BMJ 2013;347:f7585
- Rory Watson
All authors of clinical trials in the European Union will have to register on a publicly accessible database and upload a summary of results within a year of their trial’s completion, stipulates EU legislation now being finalised.
The requirements, which will apply to drug companies as well as academic researchers, are part of a wider move to streamline rules on clinical trials across the EU and represent a major victory for campaigners for transparency in research. They are also designed to facilitate cross border trials to encourage larger, more reliable trials, including those focusing on rare diseases.
The British Labour member of the …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial